Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Sharon Mates. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Sharon Mates har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:ITCI / Intra-Cellular Therapies, Inc. | Chairman and CEO, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Sharon Mates. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Sharon Mates som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
D - Sale to Issuer | −190 000 | 0 | −100,00 | 132,00 | −25 080 000 | ||
| 2025-04-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
D - Sale to Issuer | −945 235 | 0 | −100,00 | 132,00 | −124 771 020 | ||
| 2025-03-31 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | 190 000 | 190 000 | |||||
| 2025-03-31 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | −190 000 | 945 235 | −16,74 | ||||
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −10 129 | 1 135 235 | −0,88 | 131,24 | −1 329 330 | 148 988 241 | |
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 566 | 1 145 364 | 1,83 | ||||
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −19 848 | 1 124 798 | −1,73 | 131,19 | −2 603 859 | 147 562 250 | |
| 2025-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 712 | 1 144 646 | 3,69 | ||||
| 2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −16 978 | 1 103 934 | −1,51 | 128,20 | −2 176 580 | 141 524 339 | |
| 2025-03-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 969 | 1 120 912 | 3,22 | ||||
| 2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
F - Taxes | −15 233 | 1 085 943 | −1,38 | 127,00 | −1 934 591 | 137 914 761 | |
| 2025-02-04 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 30 847 | 1 101 176 | 2,88 | ||||
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 534 | 1 070 329 | −0,14 | 84,69 | −129 914 | 90 645 842 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −50 163 | 1 071 863 | −4,47 | 84,06 | −4 216 928 | 90 105 627 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 51 697 | 1 122 026 | 4,83 | 12,73 | 658 103 | 14 283 391 | |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −23 333 | 1 070 329 | −2,13 | 86,00 | −2 006 750 | 92 053 432 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −27 667 | 1 093 662 | −2,47 | 85,62 | −2 368 909 | 93 641 746 |
| 2024-12-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 51 000 | 1 121 329 | 4,76 | 12,73 | 649 230 | 14 274 518 | |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 193 | 1 070 329 | −0,58 | 73,32 | −454 091 | 78 479 947 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −28 203 | 1 076 522 | −2,55 | 72,73 | −2 051 261 | 78 297 598 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 396 | 1 104 725 | 3,21 | 12,73 | 437 861 | 14 063 149 | |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 772 | 1 070 329 | −0,54 | 73,25 | −422 771 | 78 396 355 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −29 832 | 1 076 101 | −2,70 | 72,44 | −2 161 114 | 77 955 770 |
| 2024-08-30 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 35 604 | 1 105 933 | 3,33 | 12,73 | 453 239 | 14 078 527 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −240 | 1 070 329 | −0,02 | 73,70 | −17 688 | 78 883 247 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −32 459 | 1 070 569 | −2,94 | 72,74 | −2 361 113 | 77 874 688 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 32 699 | 1 103 028 | 3,06 | 17,57 | 574 521 | 19 380 202 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −16 856 | 1 070 329 | −1,55 | 73,93 | −1 246 191 | 79 131 135 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −23 657 | 1 087 185 | −2,13 | 73,33 | −1 734 865 | 79 727 734 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 513 | 1 110 842 | 3,79 | 17,57 | 711 813 | 19 517 494 | |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −22 713 | 1 070 329 | −2,08 | 74,59 | −1 694 229 | 79 838 944 |
| 2024-08-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 713 | 1 093 042 | 2,12 | 17,57 | 399 067 | 19 204 748 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −28 680 | 1 070 329 | −2,61 | 74,46 | −2 135 435 | 79 693 807 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 28 680 | 1 099 009 | 2,68 | 17,57 | 503 908 | 19 309 588 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 369 | 1 070 329 | −0,41 | 75,47 | −329 727 | 80 777 409 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −35 011 | 1 074 698 | −3,15 | 74,58 | −2 611 075 | 80 149 580 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 39 380 | 1 109 709 | 3,68 | 17,57 | 691 907 | 19 497 587 | |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 900 | 1 070 329 | −0,18 | 77,98 | −148 163 | 83 464 791 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 682 | 1 072 229 | −0,25 | 77,21 | −207 088 | 82 790 983 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 297 | 1 074 911 | −0,40 | 76,20 | −327 432 | 81 908 326 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −44 134 | 1 079 208 | −3,93 | 75,40 | −3 327 818 | 81 375 089 |
| 2024-08-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 53 013 | 1 123 342 | 4,95 | 17,57 | 931 438 | 19 737 119 | |
| 2024-04-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 382 | 1 070 329 | 1,07 | 17,57 | 199 982 | 18 805 681 | |
| 2024-04-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 8 638 | 1 058 947 | 0,82 | 16,86 | 145 637 | 17 853 846 | |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −306 | 1 050 309 | −0,03 | 67,33 | −20 603 | 70 717 305 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 590 | 1 050 615 | −0,15 | 66,81 | −106 228 | 70 191 588 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 128 | 1 052 205 | −0,39 | 65,90 | −272 035 | 69 340 310 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −14 541 | 1 056 333 | −1,36 | 64,80 | −942 257 | 68 450 378 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 565 | 1 070 874 | 1,96 | ||||
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 754 | 1 050 309 | −0,83 | 66,93 | −585 905 | 70 297 181 |
| 2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −31 958 | 1 059 063 | −2,93 | 66,38 | −2 121 372 | 70 300 602 |
| 2024-03-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 712 | 1 091 021 | 3,88 | ||||
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 462 | 1 050 309 | −1,17 | 70,11 | −873 711 | 73 637 164 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 528 | 1 062 771 | −0,89 | 69,45 | −661 720 | 73 809 446 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −600 | 1 072 299 | −0,06 | 68,39 | −41 034 | 73 334 529 |
| 2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 590 | 1 072 899 | 2,15 | ||||
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 450 | 1 050 309 | −1,63 | 67,42 | −1 176 479 | 70 811 833 |
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −16 435 | 1 067 759 | −1,52 | 66,70 | −1 096 214 | 71 219 525 |
| 2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 33 885 | 1 084 194 | 3,23 | ||||
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −320 | 1 050 309 | −0,03 | 66,25 | −21 200 | 69 582 971 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −67 597 | 1 050 629 | −6,05 | 65,19 | −4 406 648 | 68 490 505 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 67 917 | 1 118 226 | 6,47 | 16,86 | 1 145 081 | 18 853 290 | |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 451 | 1 050 309 | −1,63 | 66,66 | −1 163 284 | 70 013 598 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −30 633 | 1 067 760 | −2,79 | 66,00 | −2 021 778 | 70 472 160 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 48 084 | 1 098 393 | 4,58 | 16,86 | 810 696 | 18 518 906 | |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 882 | 1 050 309 | −0,56 | 67,76 | −398 564 | 71 168 938 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −65 979 | 1 056 191 | −5,88 | 67,25 | −4 437 088 | 71 028 845 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 500 | 1 122 170 | −0,31 | 66,38 | −232 330 | 74 489 645 |
| 2024-01-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 75 361 | 1 125 670 | 7,18 | 16,86 | 1 270 586 | 18 978 796 | |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −44 413 | 1 050 309 | −4,06 | 54,17 | −2 405 852 | 56 895 239 |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −28 119 | 1 094 722 | −2,50 | 53,96 | −1 517 301 | 59 071 199 |
| 2023-09-19 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −27 468 | 1 122 841 | −2,39 | 53,55 | −1 470 911 | 60 128 136 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 000 | 1 150 309 | 1,77 | 3,26 | 65 200 | 3 750 007 | |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 412 | 1 130 309 | −0,12 | 44,08 | −62 241 | 49 824 021 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 153 | 1 131 721 | −1,66 | 45,06 | −863 034 | 50 995 348 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 20 565 | 1 150 874 | 1,82 | ||||
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 805 | 1 130 309 | −0,60 | 42,51 | −289 281 | 48 049 436 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −34 965 | 1 137 114 | −2,98 | 43,28 | −1 513 285 | 49 214 294 |
| 2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 41 770 | 1 172 079 | 3,70 | ||||
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 30 000 | 1 130 309 | 2,73 | 3,26 | 97 800 | 3 684 807 | |
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −22 590 | 1 100 309 | −2,01 | 47,03 | −1 062 408 | 51 747 532 |
| 2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 590 | 1 122 899 | 2,05 | ||||
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −251 | 1 100 309 | −0,02 | 49,60 | −12 450 | 54 575 326 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 502 | 1 100 560 | −0,23 | 48,70 | −121 847 | 53 597 272 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 200 | 1 103 062 | −0,20 | 47,35 | −104 170 | 52 229 986 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −22 895 | 1 105 262 | −2,03 | 46,54 | −1 065 533 | 51 438 893 |
| 2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 848 | 1 128 157 | 2,53 | ||||
| 2022-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −33 083 | 1 100 309 | −2,92 | 55,00 | −1 819 565 | 60 516 995 |
| 2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 61 696 | 61 696 | |||||
| 2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 50 167 | 50 167 | |||||
| 2022-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −38 925 | 0 | −100,00 | ||||
| 2022-03-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 38 925 | 1 133 392 | 3,56 | 2,84 | 110 547 | 3 218 833 | |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −100 | 1 094 467 | −0,01 | 50,92 | −5 092 | 55 730 260 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 240 | 1 094 567 | −1,02 | 51,61 | −580 096 | 56 490 603 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 249 | 1 105 807 | −1,01 | 52,35 | −588 885 | 57 888 996 |
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −22 589 | 45 180 | −33,33 | ||||
| 2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 22 589 | 1 117 056 | 2,06 | ||||
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 667 | 1 094 467 | −1,14 | 54,98 | −696 432 | 60 173 796 |
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −15 180 | 1 107 134 | −1,35 | 55,73 | −845 981 | 61 700 578 |
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −27 847 | 27 848 | −50,00 | ||||
| 2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 847 | 1 122 314 | 2,54 | ||||
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 954 | 1 094 467 | −0,81 | 40,10 | −359 055 | 43 888 127 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −27 138 | 1 103 421 | −2,40 | 40,80 | −1 107 230 | 45 019 577 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 804 | 1 130 559 | −0,51 | 41,72 | −242 143 | 47 166 921 |
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −41 896 | 0 | −100,00 | ||||
| 2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 896 | 1 136 363 | 3,83 | ||||
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 192 | 1 094 467 | −0,74 | 40,00 | −327 680 | 43 778 680 |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −1 075 | 38 925 | −2,69 | ||||
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 1 075 | 1 102 659 | 0,10 | 2,84 | 3 053 | 3 131 552 | |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −40 392 | 1 101 584 | −3,54 | 40,00 | −1 615 680 | 44 063 360 |
| 2021-10-18 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 416 | 1 141 976 | −0,12 | 40,00 | −56 640 | 45 679 040 |
| 2021-08-24 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 40 000 | −20,00 | ||||
| 2021-08-24 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 000 | 1 143 392 | 0,88 | 2,84 | 28 400 | 3 247 233 | |
| 2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 67 769 | 67 769 | |||||
| 2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 53 471 | 53 471 | |||||
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 100 | 1 133 392 | −0,27 | 38,91 | −120 621 | 44 100 283 |
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −24 747 | 1 136 492 | −2,13 | 39,27 | −971 815 | 44 630 041 |
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −27 847 | 55 695 | −33,33 | ||||
| 2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 27 847 | 1 161 239 | 2,46 | ||||
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 585 | 1 133 392 | −0,40 | 31,64 | −145 069 | 35 860 523 |
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −37 311 | 1 137 977 | −3,17 | 32,06 | −1 196 191 | 36 483 543 |
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −41 896 | 41 896 | −50,00 | ||||
| 2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 896 | 1 175 288 | 3,70 | ||||
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 800 | 1 133 392 | −0,25 | 30,94 | −86 632 | 35 067 148 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 200 | 1 136 192 | −0,98 | 31,39 | −351 568 | 35 665 067 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 428 | 1 147 392 | −0,56 | 30,94 | −198 882 | 35 500 308 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −27 913 | 1 153 820 | −2,36 | 31,39 | −876 189 | 36 218 410 |
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −34 341 | 0 | −100,00 | ||||
| 2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 341 | 1 181 733 | 2,99 | ||||
| 2020-12-21 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −34 000 | 0 | −100,00 | ||||
| 2020-12-21 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 000 | 1 147 392 | 3,05 | 2,74 | 93 160 | 3 143 854 | |
| 2020-11-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 131 | 1 113 392 | −1,69 | 26,91 | −514 815 | 29 961 379 |
| 2020-11-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −30 869 | 1 132 523 | −2,65 | 25,99 | −802 285 | 29 434 273 |
| 2020-11-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −50 000 | 1 163 392 | −4,12 | 25,00 | −1 250 000 | 29 084 800 |
| 2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 83 542 | 83 542 | |||||
| 2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 66 886 | 66 886 | |||||
| 2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
J - Other | −9 323 | 1 213 392 | −0,76 | 23,61 | −220 116 | 28 648 185 | |
| 2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 18 008 | 1 222 715 | 1,49 | ||||
| 2020-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −41 895 | 1 204 707 | −3,36 | 26,16 | −1 095 973 | 31 515 135 |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −16 000 | 34 000 | −32,00 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −44 000 | 0 | −100,00 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −41 895 | 83 792 | −33,33 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 000 | 1 246 602 | 1,30 | 2,74 | 43 840 | 3 415 689 | |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 44 000 | 1 230 602 | 3,71 | 2,74 | 120 560 | 3 371 849 | |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 41 895 | 1 186 602 | 3,66 | ||||
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −37 659 | 1 144 707 | −3,19 | 30,39 | −1 144 457 | 34 787 646 |
| 2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 939 | 1 182 366 | −0,67 | 29,78 | −236 423 | 35 210 859 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −34 340 | 34 341 | −50,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −11 258 | 0 | −100,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 340 | 1 190 305 | 2,97 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 258 | 1 155 965 | 0,98 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −56 | 1 144 707 | 0,00 | 34,30 | −1 921 | 39 263 450 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 000 | 1 144 763 | −0,26 | 33,25 | −99 750 | 38 063 370 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −10 722 | 1 147 763 | −0,93 | 32,43 | −347 714 | 37 221 954 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 700 | 1 158 485 | −0,32 | 31,85 | −117 845 | 36 897 747 |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −6 000 | 44 000 | −12,00 | ||||
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 000 | 1 162 185 | 0,52 | 2,74 | 16 440 | 3 184 387 | |
| 2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 17 478 | 1 156 185 | 1,53 | ||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 125 687 | 125 687 | |||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 172 697 | 172 697 | |||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 604 | 1 138 707 | −0,58 | 12,43 | −82 088 | 14 154 128 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −6 604 | 0 | −100,00 | ||||
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 539 | 1 145 311 | −0,65 | 11,82 | −89 111 | 13 537 576 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −38 059 | 1 152 850 | −3,20 | 11,38 | −433 111 | 13 119 433 |
| 2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 604 | 1 190 909 | 0,56 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −34 340 | 68 681 | −33,33 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −11 258 | 11 258 | −50,00 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 34 340 | 1 184 305 | 2,99 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 258 | 1 149 965 | 0,99 | ||||
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 478 | 1 138 707 | −1,51 | 11,09 | −193 831 | 12 628 261 |
| 2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 17 478 | 1 156 185 | 1,53 | ||||
| 2018-12-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
| 2018-12-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 1 138 707 | 4,59 | 1,50 | 75 000 | 1 708 060 | |
| 2018-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 604 | 1 088 707 | −0,60 | 17,48 | −115 438 | 19 030 598 |
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 257 | 1 095 311 | −1,02 | 17,08 | −192 270 | 18 707 912 |
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −6 604 | 6 604 | −50,00 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 604 | 1 106 568 | 0,60 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 103 021 | 103 021 | |||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 138 473 | 138 473 | |||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −11 257 | 22 516 | −33,33 | ||||
| 2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 257 | 1 099 964 | 1,03 | ||||
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −18 750 | 0 | −100,00 | |||
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −18 750 | 1 088 707 | −1,69 | 15,75 | −295 312 | 17 147 135 |
| 2017-11-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 18 750 | 1 107 457 | 1,72 | 1,50 | 28 125 | 1 661 186 |
| 2017-01-09 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 081 | 1 088 707 | −0,37 | 16,55 | −67 541 | 18 018 101 |
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
M - Exercise | −6 603 | 13 208 | −33,33 | ||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 6 603 | 1 092 788 | 0,61 | ||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
A - Award | 33 773 | 33 773 | |||||
| 2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 135 399 | 135 399 | |||||
| 2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 19 811 | 19 811 | |||||
| 2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 83 528 | 83 528 | |||||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −18 750 | 18 750 | −50,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −25 000 | 0 | −100,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −25 000 | 0 | −100,00 | |||
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 800 | 1 086 185 | −0,17 | 55,08 | −99 144 | 59 827 070 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 654 | 1 087 985 | −1,77 | 54,24 | −1 066 033 | 59 012 306 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −30 046 | 1 107 639 | −2,64 | 53,56 | −1 609 264 | 59 325 145 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 18 750 | 1 137 685 | 1,68 | 1,50 | 28 125 | 1 706 528 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 25 000 | 1 118 935 | 2,29 | 1,36 | 34 000 | 1 521 752 |
| 2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 25 000 | 1 093 935 | 2,34 | 0,60 | 15 000 | 656 361 |
| 2015-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 228 380 | 228 380 | |||||
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | −35 000 | 1 068 935 | −3,17 | 14,75 | −516 250 | 15 766 791 | |
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
| 2014-11-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 1 103 935 | 4,74 | 0,50 | 25 000 | 551 968 | |
| 2014-07-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 200 000 | 200 000 | |||||
| 2013-09-09 | 3 | NONE |
Intra-Cellular Therapies, Inc.
Common Stock |
1 053 935 |